Excellent booster response 4-6 y after a single primary dose of an inactivated hepatitis A vaccine

被引:35
作者
Iwarson, S [1 ]
Lindh, M
Widerström, L
机构
[1] Sahlgrens Univ Hosp, Dept Infect Dis, SU OSTRA, Div Infect Dis, SE-41685 Gothenburg, Sweden
[2] Sahlgrens Univ Hosp, Inst Internal Med, Dept Clin Virol, SE-41685 Gothenburg, Sweden
关键词
D O I
10.1080/00365540110077362
中图分类号
R51 [传染病];
学科分类号
100401 [流行病与卫生统计学];
摘要
We studied the immune response of an inactivated hepatitis A vaccine (Havrix 1440(TM)) given to middle-aged travellers 4-6 y after a single, primary dose. Anti-HAV antibodies in serum were checked before and 28-35 d after the booster. All 25 vaccinees showed an impressive anamnestic booster response (geometric mean titres 32 and 2993 mIU/ml before and after the booster, respectively). The study confirms experimental data indicating that 1 dose of inactivated hepatitis A vaccine induces a long-term proliferative T-cell response in addition to producing anti-HAV antibody. As recall memory for this vaccine is elicited several years after a single dose there is probably no need for a second vaccine dose.
引用
收藏
页码:110 / 111
页数:2
相关论文
共 6 条
[1]
Hepatitis A virus-specific humoral and cellular immune responses following immunization with a formalin-inactivated hepatitis A vaccine [J].
Cederna, JB ;
Klinzman, D ;
Stapleton, JT .
VACCINE, 1999, 18 (9-10) :892-898
[2]
Iwarson S, 1998, J Travel Med, V5, P80, DOI 10.1111/j.1708-8305.1998.tb00468.x
[3]
Inactivated hepatitis A vaccine booster given ≥24 months after the primary dose [J].
Landry, P ;
Tremblay, S ;
Darioli, R ;
Genton, B .
VACCINE, 2000, 19 (4-5) :399-402
[4]
A CONTROLLED TRIAL OF A FORMALIN-INACTIVATED HEPATITIS-A VACCINE IN HEALTHY-CHILDREN [J].
WERZBERGER, A ;
MENSCH, B ;
KUTER, B ;
BROWN, L ;
LEWIS, J ;
SITRIN, R ;
MILLER, W ;
SHOUVAL, D ;
WIENS, B ;
CALANDRA, G ;
RYAN, J ;
PROVOST, P ;
NALIN, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (07) :453-457
[5]
Booster vaccination with recombinant hepatitis B vaccine four years after priming with one single dose [J].
Wiström, J ;
Ahlm, C ;
Lundberg, S ;
Settergren, B ;
Tärnvik, A .
VACCINE, 1999, 17 (17) :2162-2165
[6]
SEROLOGY AND INTERFERON-PRODUCTION DURING THE EARLY PHASE OF ACUTE HEPATITIS-A [J].
ZACHOVAL, R ;
KROENER, M ;
BROMMER, M ;
DEINHARDT, F .
JOURNAL OF INFECTIOUS DISEASES, 1990, 161 (02) :353-354